Nemours Childrens Health, Jacksonville

Jacksonville, Florida 32207

1 studies enrolling now · 5 studies all time

What they study most

Esophagitis, Neurogenic Detrusor Overactivity, Pediatric Cancer, Quality of Life, Sickle Cell Disease, Vascular Anomaly

Studies at this site

• Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC — Recruiting now
• Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years — Stopped early
• Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions — Stopped early
• Symptom Screening Linked to Care Pathways — Completed
• Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options — NO_LONGER_AVAILABLE